Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:08 AM
Ignite Modification Date:
2025-12-25 @ 4:08 AM
NCT ID:
NCT00316420
Eligibility Criteria:
Inclusion Criteria:
* Metastatic or unresectable pancreatic cancer
* No prior chemotherapy except radiation-sensitizing doses of 5-FU
* No radiotherapy less than 4 weeks prior to the start of the study
Exclusion Criteria:
* Prior unanticipated severe reaction to fluoropyrimidine therapy or known hypersensitivity to 5-FU
* Moderate to severe renal impairment
* Uncontrolled diabetes
* Inability to swallow tablets
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00316420
Study Brief:
Protocol Section:
NCT00316420